Swiss healthtech targeted personal fairness agency, MTIP has introduced the closing of its MTIP Fund II at $250 million (€221m) in capital commitments.
The oversubscribed fund, which closed above its goal of $225 million (€199m), continues its predecessor fund’s technique of investing in rising and revolutionary healthtech firms primarily throughout Europe.
MTIP Fund II is a chosen ‘darkish inexperienced’ fund, underneath Article 9 of the EU’s Sustainable Finance Disclosure Regulation, that means its goal is to focus on sustainable investments.
After a robust first closing in late March of this yr, MTIP accomplished the ultimate closing of its second fund with capital raised from new and present buyers, together with a number of famend institutional buyers, pension funds, household places of work, hospitals, and foundations.
MTIP has already made 5 investments out of its second fund: Swiss way of life teaching app Oviva, Swedish scientific trial recruitment agency Trialbee, Telefonica spin-out Koa Well being, Greek AI startup Intelligencia and Barcelona-based symptom checker app Mediktor.
WHY IT MATTERS
MTIP Fund II gives progress capital to entrepreneurial and fast-growing digital well being and digitally linked medical system firms. The agency says that its funding crew carefully observes related healthcare and societal traits to supply probably the most important gamers in numerous markets.
It seeks to capitalise on Europe’s quickly increasing healthtech panorama, offering as much as €25 million in funding to assist promising scale-up firms develop into world leaders.
THE LARGER CONTEXT
The COVID-19 pandemic accelerated innovation within the healthcare sector and led to the adoption of latest applied sciences.
In response to CB Insights’ State of Enterprise Q3’21 Report, buyers have poured $97.1 billion (€85.9bn) into healthcare this yr – greater than every other trade. The sector has collected 22% of the overall quantity raised up to now in 2021.
A report on the way forward for healthcare launched in April by Dealroom, Inkef Capital and MTIP, discovered that the mixed worth of Europe-based healthtech firms had grown from $8 billion (€7.08bn) to $41 billion (€36.3bn) between 2016 and 2021. This progress was introduced on by telemedicine, operation software program and insurtechs.
The report additionally discovered enterprise capital funding exercise has moved past telehealth, to distant monitoring, synthetic intelligence (AI) merchandise and digital therapeutics.
ON THE RECORD
Dr Christoph Kausch, managing associate at MTIP, stated: “We’re excited to announce the profitable closing of our second fund and proceed our mission to construct the well being tech leaders of tomorrow. The belief our buyers have put in us is a superb endorsement of our technique that’s constructed on our singular focus and confirmed method to worth creation.”
Dr Andreas Schönenberger, CEO at Sanitas and investor within the MTIP Fund II, stated: “MTIP has a novel experience in well being tech and fosters innovation on this under-served personal fairness sector. Our collaboration with MTIP provides us entry to revolutionary well being tech options that allow us to generate added worth for our prospects.”